Drug details

Dalvance (dalbavancin for injection)

type of Glycopeptides

Dalvance (dalbavancin) for injection is a lipoglycopeptide used to treat adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible isolates of the following Gram-positive microorganisms: Staphylococcus aureus (including methicillin susceptible and methicillin-resistant strains), Streptococcus pyogenes, Streptococcus agalactiae and Streptococcus anginosus group (including S. anginosus, S. intermedius, S. constellatus).

This drug may have the following side effects:

• nausea,
• headache,
• vomiting,
• diarrhea,
• rash, and
• itching

The following drugs are related to Dalvance, either as a replacement or used together:

• Principen (ampicillin)
• Bactroban Cream (mupirocin calcium cream)
• Bactroban Nasal (mupirocin calcium ointment)
• Bactroban Ointment (mupirocin)
• Duricef (Brand Name is Discontinued) (cefadroxil)
• Suprax (cefixime)
• Cefzil (cefprozil)
• Teflaro (ceftaroline fosamil injection for intravenous (iv) use)
• Cubicin (daptomycin injection)
• Cubicin RF (daptomycin injection)
• Zyvox (linezolid)
• Lorabid (loracarbef)
• Vancocin (vancocin)
• Vancomycin Hydrochloride (vancomycin hydrochloride injection)